Avian Vaccine Services LLC

Avian Vaccine Services LLC is a for-profit limited liability company headquartered in Norwich, Connecticut, that specializes in providing high-quality poultry products and related services to support federal research, vaccine development, and public health initiatives. Registered in SAM.gov since November 2022, the company has established itself as a critical supplier to multiple federal agencies by providing specialized biological materials that meet stringent laboratory and regulatory standards. The company's core competency lies in supplying Specific Pathogen Free (SPF) eggs and live poultry products that are essential for developing candidate vaccine viruses, conducting immunological research, and supporting disease prevention efforts across the federal government.

Avian Vaccine Services LLC has demonstrated consistent success in securing federal contract awards across multiple agencies and has built a diversified portfolio of prime contracts. The company has been awarded numerous purchase orders and delivery orders from the Centers for Disease Control and Prevention (CDC) for SPF fertile eggs, embryonated chicken eggs, and related products supporting influenza vaccine development and the Immunization and Respiratory Diseases Division. The National Institute of Allergy and Infectious Diseases (NIAID) has awarded multiple contracts to the company for SPF eggs, purified influenza virus antigens, avian vaccine incubation services, and standing orders for 4-week-old chickens used in vaccine research and structural studies of influenza nanoparticles. The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) and Agricultural Research Service (ARS) have been significant customers, procuring SPF eggs through both individual purchase orders and delivery orders. The Food and Drug Administration (FDA) has also contracted with Avian Vaccine Services LLC for pathogen-free chicken eggs used in candidate vaccine virus production and testing. The company's contract awards have ranged from approximately $11,598 to $487,859 per individual task, with no set-aside designations applied to the majority of awards, though the FDA did apply small business set-aside designations to two contracts totaling approximately $36,888. All contracts have been awarded on a firm fixed-price basis, reflecting the company's established reliability and the well-defined nature of its product specifications.

Avian Vaccine Services LLC currently holds a single-award Indefinite Delivery Contract (IDC) with the USDA Animal and Plant Health Inspection Service valued at $2,256,875.40, with a performance period extending through October 11, 2027. This five-year contract, titled "New Contract Resulting from a Novation Agreement 5 Year IDIQ Contract for Specific Pathogen Free (SPF) Embryonating Chicken Eggs for CVB and NSVL," was awarded on March 20, 2023, and represents a consolidation of the company's relationship with USDA for supplying SPF embryonating chicken eggs to support disease prevention and public health efforts. Multiple delivery orders have been issued against this IDC, including a $460,012.80 delivery order from USDA APHIS Veterinary Services for October 2023 through October 2024 performance in Ames, Iowa, and a $249,327 delivery order from USDA APHIS Marketing and Regulatory Programs Business Services Emergency Management Safety and Security Division for April 2023 through October 2027 performance in Norwich, Connecticut. Additionally, a more recent delivery order valued at $448,056.60 was awarded in November 2025 for performance concluding October 11, 2026, and another valued at $487,858.80 was awarded in October 2024, demonstrating ongoing utilization of this contract vehicle. The IDC provides the contractual framework for the company's sustained engagement with USDA while allowing flexibility for federal agencies to issue delivery orders based on evolving public health and research requirements.